Seraseq® ctDNA BRAF V600E Mutation Mix (AF1%)

The Seraseq® ctDNA BRAF V600E Mutation Mix is a purified ctDNA reference material for NGS-based liquid biopsy assays targeting BRAF V600E mutation, a pan-cancer oncogenic driver and target for BRAF/MEK inhibitor therapy. Formulated at AF1% allele frequency, it enables limit-of-detection studies, sensitivity characterisation, and routine quality control of ctDNA detection panels.

Key features:

• Targets clinically actionable BRAF V600E mutation, a pan-cancer oncogenic driver and target for BRAF/MEK inhibitor therapy
• Allele frequency AF1% for sensitivity and LOD characterisation
• Purified ctDNA for direct library preparation input
• Precisely quantitated by digital PCR for reliable, reproducible performance